Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
T.PYR: Contract Toward Titanium Powder Supply & Distribution Agreement with Asian Materials Co. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Wuhan General Group Inc (EM) WUHN

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic
Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.

Current News (EXPM:WUHN)

Wuhan General Group China Announces Corporate Update

ACCESS Newswire May 17, 2022

Dr AnnaRx Announces Rob Simbowe CBD Muscle and Joint Rubs

ACCESS Newswire March 30, 2022

Medspresso and Liviana Carried by 100 Independent South African Retailers

ACCESS Newswire March 28, 2022

M2Bio Sciences Attending Master Investor Show in London, UK

ACCESS Newswire March 16, 2022

M2Bio Labs Offers Ketamine IV & Personalized Supercharged Vitamin IV Drip

ACCESS Newswire March 10, 2022

Medspresso Joins the Speciality Coffee Association of South Africa

ACCESS Newswire February 28, 2022

Medspresso Launches CBD and Functional Mushroom Single Serve Sachets

ACCESS Newswire February 1, 2022

Wuhan General Group Launches Mental Illness Drug Discovery Company Neurai Life Sciences

ACCESS Newswire January 19, 2022

M2Bio Rolls Out Sustainable Packaging for Liviana

ACCESS Newswire December 31, 2021
View More News ››

Opinion & Analysis (EXPM:WUHN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:WUHN)

F19 and F20 Executive summary

Fiscal Year 2020 Highlights Versus Fiscal 2019 Net income for the year $409,996 US, compared to $0 US Increase in current...
joe9904 - February 2, 2021

M2Bio Sciences Updates on Psilocybin Magic Mushroom Clinical

http://thestocksmarket.net/2020/10/30/m2bio-sciences-updates-on-psilocybin-magic-mushroom-clinical-trials-and-intellectual-property-ip/
supergarvis - October 30, 2020

RED LIGHT HOLLAND $TRIP 🍄🍄🍄🍄🍄

CEO is in holland currently building shareholder value Instagram Post Red Light Holland Announces Arrangement to Launch Sale of...
pampleemousse - September 11, 2020

Psychedelic highlights | july 06-10

https://thecannabisstock.com/2020/07/12/psychedelic-highlights-july-06-10/
supergarvis - July 12, 2020

RE:Clarify !

WUHN on the OTC (us side)
supergarvis - July 8, 2020

Clarify !

The ticker symbol does not seem to work. also bid 0 ask 0 
maxine333 - July 6, 2020
View more Bullboard ››

Cannabix Technologies Inc.

Cannabix Technologies Inc.

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer technologies for employers, law ...
View More »

Podcasts